Risk of pulmonary emboli after removal of an upper extremity central catheter associated with a deep vein thrombosis.
PMID:
A pilot study of central venous catheter survival in cancer patients using low-molecular-weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study).
PMID:
Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis.
Vedantham S, Goldhaber SZ, Julian JA, Kahn SR, Jaff MR, Cohen DJ, Magnuson E, Razavi MK, Comerota AJ, Gornik HL, Murphy TP, Lewis L, Duncan JR, Nieters P, Derfler MC, Filion M, Gu CS, Kee S, Schneider J, Saad N, Blinder M, Moll S, Sacks D, Lin J, Rundback J, Garcia M, Razdan R, VanderWoude E, Marques V, Kearon C; ATTRACT Trial Investigators.
N Engl J Med. 2017 Dec 7;377(23):2240-2252. doi: 10.1056/NEJMoa1615066.
PMID:29211671
Hemodialysis Catheter-Related Central Venous Thrombosis: Clinical Approach to Evaluation and Management.
Gunawansa N, Sudusinghe DH, Wijayaratne DR.
Ann Vasc Surg. 2018 Aug;51:298-305. doi: 10.1016/j.avsg.2018.02.033. Epub 2018 May 29.
PMID:29772317
Peripherally inserted central venous catheter (PICC) in outpatient and inpatient oncological treatment.
Mielke D, Wittig A, Teichgräber U.
Support Care Cancer. 2020 Oct;28(10):4753-4760. doi: 10.1007/s00520-019-05276-0. Epub 2020 Jan 22.
PMID:31970514
Risk of pulmonary emboli after removal of an upper extremity central catheter associated with a deep vein thrombosis.
Houghton DE, Billett HH, Gaddh M, Onadeko O, George G, Wang TF, Oo TH, Feng M, Dasgupta M, Jaglal M, Streiff MB, Simpson P, Gali R, Baumann Kreuziger L.